With the Clasico at Barcelona just around the corner, Gareth Bale is injured and the 27-year-old will be sidelined for up to three months after ankle surgery on Tuesday. It’s terrible news for Real Madrid. B ale out for up to three months with ankle injury Bale missed Madrid’s UEFA Super Cup clash against Sevilla in Trondheim back in August after returning late from his holidays because of his run to the semi-finals of Euro 2016with Wales. But he has been virtually ever-present since then, featuring in 11 of his side’s 12 games in La Liga and in all five in the Champions League – each of them as a starter. With Cristiano Ronaldo still sidelined following the knee injury he picked up in the final of Euro 2016, Bale began the season with a bang at Anoeta, scoring two of his team’s goals in the 3-0 win away to Real Sociedad. Since then, he has also netted versus Eibar, home and away to Legia Warsaw and a double in the 3-0 win over Leganes. Against Atletico on Saturday night, he was used in a deeper role in midfield and set up Ronaldo’s third in a memorable Madrid derby win for his team. http://jacekingzone.adafire.org/2016/11/10/rapid-products-in-foot-surgery-guidelines/That came after Zidane had picked a different formation to compete with Diego Simeone’s side. With Bale until 2017 after limping off with an ankle injury in Lisbon on Tuesday, Zidane must shuffle the pack again ahead of the Clasico. View photos Real Madrid are at home toSporting Gijon on Saturday, with a Copa del Rey clash against Cultural Leonesa to come on Wednesday night – also at the Santiago Bernabeu. And while the Blancos should be able to negotiate both of those fixtures comfortably, the trip to Barcelona represents another type of test altogether.navigate to this site
For the original version including any supplementary images or video, visit http://sports.yahoo.com/news/bale-blow-not-fatal-madrid-173751137.html
net sales of XIAFLEX were $47.7 million, an increase of 19 percent compared to the third quarter of 2015. BSTC closed Thursday’s trading at $49.14, up 3.52%. Champions Oncology Inc. ( CSBR ) has been awarded a $2 million contract by a pharmaceutical customer, the identity of which has not been disclosed. The contract represents the largest pre-clinical pharmacology contract in Champions’ history and is almost double the size of the largest previous contract. CSBR closed Thursday’s trading at $1.75, up 1.16%. EyeGate Pharmaceuticals Inc. ( EYEG ) is all set to release top-line results from its initial pilot study evaluating the ability of EyeGate OBG to accelerate ocular surface re-epithelialization following photorefractive keratectomy by the end of this year. The company plans to pursue U.S. regulatory clearance of its EyeGate Ocular Bandage Gel (“EyeGate OBG”) via the De Novo 510(k) pathway. EYEG closed Thursday’s trading at $1.45, down 0.68%.
For the original version including any supplementary images or video, visit http://www.rttnews.com/story.aspx?Id=2717627
You may also be interested to read
- neuropathic foot pain icd 9 code
- why not look here